Moderna CEO Stephane Bancel on Monday pushed back on criticism of the company's plans to raise the price of its mRNA-based COVID-19 vaccines by 400 percent, arguing that the billions of dollars in fed...
The US Food and Drug Administration's committee of independent vaccine experts gathered Thursday to discuss the future of COVID-19 shots. The meeting seemed primed for explosive debate. Ea...
Moderna's mRNA-based vaccine against RSV (respiratory syncytial (sin-SISH-uhl) virus) was effective at preventing disease in older adults, according to preliminary, top-line results of an ...
Routine childhood vaccination coverage continues to slip among US kindergarteners, falling from 95 percent--the target coverage--prior to the pandemic to 94 percent in the 2020-2021 school...
Moderna is considering raising the price of its COVID-19 vaccine by over 400 percent--from $26 per dose to between $110 and $130 per dose--according to a report by The Wall Street Journal....
COVID vaccines remain the safest way to reduce the chance that SARS-CoV-2 can put you in the hospital and are a critical component of the public health campaign against the pandemic. Yet, ...